Streetbeat News

Stock Prices

RNA

Avidity Biosciences reported over 50% reduction in DUX4 regulated genes in its Phase 1/2 FORTITUDE trial for facioscapulohumeral muscular dystrophy (FSHD). The company plans to accelerate the initiation of registrational cohorts. The investigational therapy, delpacibart braxlosiran (AOC 1020), showed promising results in muscle strength and patient outcomes, with favorable safety and tolerability.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:13 am

CYN

NVDA

Cyngn Inc. (NASDAQ:CYN) has announced advancements in its AI-driven computer vision technology for industrial autonomous machines, powered by NVIDIA (NASDAQ:NVDA) hardware and CUDA acceleration libraries. The DriveMod system, which has been deployed on vehicles from manufacturers like BYD and John Deere, showcases sophisticated features such as pallet enumeration and non-standard pallet pocket detection.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:11 am

RGNX

Regenxbio has reiterated its financial guidance previously provided on May 8, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:11 am

FPAY

PHIO

PRTS

Insiders are buying shares of CarParts.com, Phio Pharmaceuticals, and FlexShopper, indicating their confidence in these companies. Notable transactions include CarParts.com Director Jim Barnes buying 94,000 shares, Phio Pharmaceuticals CEO Robert J Bitterman acquiring 1,000 shares, and FlexShopper Director Howard Dvorkin purchasing 90,921 shares.

Portfolio Pulse from Avi Kapoor

June 12, 2024 | 11:07 am

TSHA

Taysha Gene Therapies announced it will host a webcast on June 18, 2024, to present clinical data from its Reveal Phase 1/2 trials.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:03 am

AAPL

DIA

SPY

On June 11th, U.S. stock markets closed mixed with the S&P 500 and Nasdaq reaching record highs, driven by a surge in Apple shares. Apple was upgraded by DA Davidson, citing AI advancements. The NFIB Small Business Optimism Index increased. Most S&P 500 sectors ended lower, while IT and communication services stocks closed higher. The Dow Jones closed down, while the S&P 500 and Nasdaq closed up. Asian markets were mixed, and European markets showed gains. Crude oil prices increased, while natural gas declined.

Portfolio Pulse from Akanksha Bakshi

June 12, 2024 | 10:45 am

AFMD

Affimed anticipates that its cash, equivalents, and short-term investments will support its operations into the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 10:35 am

NATH

Nathan's Famous reported a 20% increase in Q4 EPS to $0.96 and a 5.75% increase in sales to $28.99 million compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 10:33 am

TGT

Target has announced an increase in its quarterly dividend by 1.8%, raising it to $1.12 per share from the previous $1.10. The dividend is payable on September 10, 2024, to shareholders of record as of August 21, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 10:32 am

ELV

Elevance Health has reaffirmed its FY24 adjusted EPS guidance to be greater than $37.20, slightly below the consensus estimate of $37.28.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 10:18 am